Skip to main content

Assessment of pre-analytical sample handling conditions for comprehensive liquid biopsy analyses.

Gerber T, Taschner-Mandl S, Saloberger-Sindhöringer L, Popitsch N, Heitzer E, Witt V, Geyeregger R, Hutter C, Schwentner R, Ambros IM, Ambros PF

Publication: J Mol Diagn (2020)PMID: 32497717View on PubMed

Purpose

The purpose of this paper was to investigate the effect of tube type, pre- and post-centrifugation storage, and blood processing method on the cell free DNA (cfDNA) yield, size distribution, next-generation sequencing (NGS) metrics, and cell profile.

Conclusion

Although cfDNA levels were comparable in plasma from blood collected in PAXgene ccfDNA, Streck BCT, Roche cfDNA, and EDTA tubes, cfDNA levels were higher and the ratio of MYCN/NAGK more variable in heparin plasma. Serum had higher levels of cfDNA and lower MYCN/NAGK ratios than PAXgene or EDTA plasma. cfDNA yield was stable when blood was stored at room temperature for up to 48 h in PAXgene ccfDNA, Streck BCT, or Roche cfDNA tubes or when stored at 4°C in EDTA tubes or clot activator tubes but cfDNA yield increased with room temperature storage of blood in heparin, EDTA tubes, or clot activator tubes. Storage of serum isolated from clot activator tubes resulted in a small but significant increase in cfDNA but storage of serum from gel tubes resulted in increasing variability in DNA yield and a significant increase in DNA contamination after 72 h at room temperature.

Library yield, percentage mapped reads, and duplication rates were comparable in plasma and serum specimens and when plasma was obtained by centrifugation and density gradient centrifugation. The calculated tumor fraction was lower in the serum specimen than the matched plasma specimen.

Cell profiles were dependent on tube type, processing delay, and processing method but was less affected by tube type and processing delay when plasma was obtained by density gradient centrifugation.

Studies (6)

Purpose

The purpose of the study was to compare cfDNA yield, size distribution, and ddPCR metrics in plasma from blood collected and stored in different tube types. Blood was collected from 22 healthy volunteers by venipuncture into Streck cell-free DNA BCT CE tubes, Roche cell-free DNA collection tubes, Lithium heparin tubes, KEDTA S-MONOVETTE tubes, and PAXgene Blood ccfDNA tubes and stored for 2, 4, 12, 24, or 48 hours at room temperature or in EDTA tubes at 4°C before centrifugation. After addition of buffered formaldehyde to the K2EDTA tubes, plasma was obtained by centrifugation at 1600 x g for 10 min at 4°C twice and then stored at -80°C until DNA extraction. cfDNA was isolated from plasma using the QIAamp Circulating Nucleic Acid Kit, quantified using Qubit dsDNA Assay Kit, and the size distribution was evaluated using the High Sensitivity DNA 5000 Kit on a TapeStation. MYCN and NAGK copy number were further quantified by droplet digital PCR (ddPCR) and real-time PCR.

Summary of Findings

Although cfDNA levels were comparable in plasma from blood collected in PAXgene ccfDNA, Streck BCT, Roche cfDNA, or EDTA tubes; they were 2.4-fold higher when blood was collected in heparin tubes.  Further, ddPCR failed in 5 of 15 specimens and the ratio of MYCN/NAGK was more variable when collected in heparin tubes compared to all other tube types. cfDNA yield was stable when blood was stored at room temperature for up to 48 h in PAXgene ccfDNA, Streck BCT, or Roche cfDNA tubes but there was a significant increase in cfDNA yield after 24 h in heparin tubes (17-fold, P<0.0001) or EDTA tubes (approximately 2-fold, P<0.0001). Along with the increase in cfDNA yield in heparin and EDTA tubes, there was a decrease in the abundance of short fragments at 24 and 48 h, respectively. When EDTA blood was stored at 4°C instead of room temperature, levels of cfDNA and the relative abundance of short fragments remained stable for the 24 h period evaluated. In addition, storage of blood for 24 h at room temperature in Streck BCT or EDTA tubes or for 48 h in Roche cfDNA tubes resulted in increased variability in the ratio of MYCN/NAGK but the number of informative droplets remained stable.

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    Other PreservativePAXgeneStreck/BCTNone (Fresh)
  • Diagnoses

    Normal
  • Platforms

    DNAAutomated electrophoresis/Bioanalyzer
    DNAFluorometry
    DNADigital PCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionType of collection container/solution
    KEDTA S-MONOVETTE tubes
    Lithium heparin
    PAXgene Blood ccfDNA tubes
    Roche cell-free DNA collection tube
    Streck cell-free DNA BCT CE
    Biospecimen Aliquots and ComponentsCentrifugation
    Centrifugation delays investigated
    StorageStorage duration
    0 h
    12 h
    2 h
    24 h
    4 h
    48 h
    StorageStorage temperature
    4°C
    Room temperature